About the project

What Embr is. What it is not.

An independent research publication on mattress chemistry and sleep environment safety. Founded 2026 in Canada. No affiliate relationships.

About Ken

My name is Ken Eyjolfson. Embr started because my wife developed an autoimmune condition, and I started paying close attention to what we were exposed to at home — what was in the air, in our food, and in the surfaces we spent the most time on. The mattress was where I spent the most time in closest contact with the most porous surface in the house, and the more I looked into what was in it, the more I realized I was thinking about it from a particular vantage point: someone who's sensitive, who has every reason to want safer sleep, who's trying to make a decision and feel okay about it. That's the perspective Embr is built for.

I'm a 19-year career firefighter. I'm also an entrepreneur — I own Mr. Liquidator, a mattress retail outlet in British Columbia. I run both businesses, and I'm naming the second one here because the only honest version of where this work comes from has me inside the industry I'm researching. The retail outlet is what gave me visibility into the parts of the category consumers can't see from the outside — the foam chemistry side, the fiberglass tier, the line between what manufacturers disclose and what they don't. Embr is structurally separate from Mr. Liquidator. No commissions, no affiliate links, no recommendations driven by inventory.

Why I'm doing this is harder to make sound official, so I'll just say it plainly: I care. My adult life has been spent in jobs where caring is the work — running into fires, talking with customers, listening to people's stories. I'll also tell you that I live with harm-based OCD — a condition that makes me unusually careful about not causing harm to others, which I've come to think is part of why I take this work seriously. I genuinely like the work of looking at a problem someone else has decided is solved and asking whether there's another way through. I don't think foam mattresses are evil. Most people can't afford a four-thousand-dollar organic mattress, the value engineering that makes a foam mattress affordable is real, and I sell them. What I want is for the people who choose a foam mattress — for budget, for back support, for any of the legitimate reasons — to be able to do so with their eyes open about what's inside, and the option to do something about the chemistry they're sleeping on if they need to.

That's what Embr is. It is not medical advice. It does not treat or prevent disease. It is independent research, openly published, with citations included so anyone can check the work. If I've gotten something wrong, tell me — hello@embrsleep.com — and I read everything that comes in.

Find me on Ken Eyjolfson on LinkedIn.

What this publication is

Embr investigates the chemistry of mattresses and the environments people sleep in. We score products against a transparent rubric, translate the peer-reviewed literature for a general audience, and publish what is known, what is reasoned, and what remains open.

The work exists because the existing category of mattress-review publishing has been structurally captured by affiliate revenue. Every major publication in this space — GoodBed, Sleepopolis, Mattress Clarity, NapLab — earns commission on mattress sales. That dynamic bends editorial decisions in ways the people inside it often cannot see. We are not smarter or more disciplined than the founders of those publications. We are building a different structure.

Founding commitments

No affiliate relationships. Embr does not accept commission, referral fees, sponsorship, or product placement of any kind. Scores are not for sale. The full version of this commitment — independence policy, funding disclosure, AI-assistance disclosure, sourcing standard, and corrections protocol — is published on the Editorial Standards page.

The methodology is open. The full scoring rubric, every weight, and the citation behind every score are published at embrsleep.com/methodology. Anyone can audit any score we publish.

Every claim is tagged. Peer-reviewed, inferred, or speculation. The reader always knows what kind of claim they are reading. This is not legal cover — it is a model of the kind of thinking we want readers to develop for themselves.

The project is also developing products. Embr is developing tools designed to address the chemistry gaps the research identifies. When products launch, they will be evaluated against the same evidence standards applied throughout this publication.

When we are wrong, we say so. Corrections are timestamped and published. Old versions are archived. We do not quietly edit errors out of existence.

Contact

For corrections, documentation disputes, editorial questions, or research collaboration inquiries:

hello@embrsleep.com

Response time: within 7 business days for corrections; within 14 days for other inquiries.